Toxic tail strategies for managing old exposures when purchasing new practices
This presentation is the property of its rightful owner.
Sponsored Links
1 / 31

Toxic Tail: Strategies for Managing Old Exposures When Purchasing New Practices PowerPoint PPT Presentation


  • 72 Views
  • Uploaded on
  • Presentation posted in: General

Toxic Tail: Strategies for Managing Old Exposures When Purchasing New Practices. Cayman Captive Forum ASHRM/IMAC Reciprocal Session 2:00pm – 2:55pm December 4, 2013. Disclosure. We have no potential conflicts of interest to disclose Mary Anne Hilliard, Children’s National, Washington DC

Download Presentation

Toxic Tail: Strategies for Managing Old Exposures When Purchasing New Practices

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Toxic tail strategies for managing old exposures when purchasing new practices

Toxic Tail: Strategies for Managing Old Exposures When Purchasing New Practices

Cayman Captive Forum

ASHRM/IMAC Reciprocal Session

2:00pm – 2:55pm

December 4, 2013


Toxic tail strategies for managing old exposures when purchasing new practices

Disclosure

We have no potential conflicts of interest to disclose

  • Mary Anne Hilliard, Children’s National, Washington DC

  • Larry Smith, MedStar Health


Toxic tail strategies for managing old exposures when purchasing new practices

Disclosure

I would like to disclose the following relationship(s):

Mike Poe, Towers Watson           Actuary

I have agreed to present the material in a fair and unbiased manner. 


Toxic tail strategies for managing old exposures when purchasing new practices

Introduction of Speakers/Panel & Topics

  • Introductions:

    • Mary Anne Hilliard, Children’s National, Washington DC

    • Larry Smith, MedStar Health

    • Mike Poe, Towers Watson

  • Topics:

    • What are the risk financing options?

    • What are the risks and issues around “prior acts” exposures?

    • How do we address or manage these?


Toxic tail strategies for managing old exposures when purchasing new practices

Background

  • Health care reform has and will continue to require alignment with physicians:

    • Bundled payments

    • Quality

    • Patient care delivery model – medical home

    • Increase in employment

    • Strong affiliations where employment not allowed

  • The issues and costs of the “prior acts coverage” for physicians can be significant

  • Issues arise because of the predominance of claims made coverage


Toxic tail strategies for managing old exposures when purchasing new practices

Increase in Physician Employment 2013 Aon Benchmark

  • Non-University hospital systems are increasingly employing physicians, and employing surgeons faster than other specialties. Hospitalists are the fastest growing specialty at community hospitals.

2013 Aon Benchmark Study


Toxic tail strategies for managing old exposures when purchasing new practices

Employed Physicians and Cost Savings

  • Our study found that a majority of hospitals systems self-insure the primary layer of coverage for their employed physicians.

  • Bringing the physicians into the risk financing program does appear to have cost savings compared to leaving them in the commercial market due to joint defense and reducing frictional costs.

2013 Aon Benchmark Study


Toxic tail strategies for managing old exposures when purchasing new practices

Employed Physicians Claims Made Considerations – Prior Acts and Tail Coverage

To Be Updated

  • The overwhelming majority of programs provide claims made coverage for employed physicians

  • Rarely do hospital systems provide prior Acts coverage to employed physicians, however, a majority are providing Tail coverage.

  • Potential exists to have multiple arrangements with physicians as these benefits are typically negotiated. Can be administratively burdensome and lead to underfunding if promised benefits are not accurately tracked.

2013 Aon Benchmark Study

2013 Aon 2013 Aon BenchmarkStudy


Toxic tail strategies for managing old exposures when purchasing new practices

What are the Risk Financing Options?

  • The hospital assumes the prior acts exposure in their captive or self insurance program

  • Physician buys a tail policy from the current commercial insurer

  • Hospital funds the purchase of the “prior acts” for the physician

  • Hospital partners with commercial insurer to provide “prior acts coverage” for the physician upon employment

In addressing each of the options, our panel will focus on the issues of Exposures, Risk Management, Claims, and Financing


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

What Are The Exposures, Risk Management, Claims, Financing Issues And Implications When The Health Care System Assumes The Prior Acts Exposure In Its Captive Or Self Insurance Program?

Panel Discussion


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

Exposures:

  • We often have an understanding of the risks and exposures when the physicians have had a strong association with the hospital

    • majority of physicians’ practice at your hospital

    • credentialing history

    • claims experience where physician and hospital named in the same suit

  • Medical malpractice may be the main focus of evaluation – but what about the other exposures of the professional corporation and its employees?

  • Current coverage form and status of current insurer

  • Potential from compensable events which have not been reported

  • How do we address the exposures of physicians with whom we have not had a strong affiliation?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

Risk Management Implications:

  • What pre-employment strategies do we initiate to better understand the exposures? Risk management assessment of the practice?

  • Is there a hospital policy on the assumption of prior acts?

  • Are we treating all physicians the same?

  • Is there an underwriting application and process in place?

  • Are CMS and other quality indicators and practice patterns considered?

  • What is the interphase between risk management and the credentials process?

  • Use of independent underwriters

  • Orientation to hospitals’ risk management program


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

  • Underwriting and risk evaluation process should include the following:

    • Application

    • Interface with credentials process and quality indicators

    • Complete loss history

    • Complete practice history (i.e., location of previous practice activities)

    • Specialty (are you really going to insure an OB tail?)

    • Rating plan/actuarial input

  • Goal is to minimize chance of large claims reported after tail inception date

    • Highlights need for full and complete reporting to the previous carrier

    • Review incident/PCE reports to confirm notice provided

      • More complicated if carrier has a “demand” trigger

      • If so, gain understanding of incidents/PCEs for which no demand has been received


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

Claims Management Implications:

  • Thorough review of all past claims

  • Consent to settle as an employee vs. prior insurer

    • Is the physician’s consent to settle even required?

  • Joint defense of claims

  • Do you have sufficient systems and claims professionals to handle the claims?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

  • How are “prior acts” claims going to be managed?

    • What if they arise from acts outside your hospital system?

  • What limits of liability for prior acts will the system provide?

    • $1M/$3M or full program limits?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

Costs and Risk Financing Implications:

  • Prior acts coverage can be very expensive regardless of who pays for it

    • 150%–250% of mature claims-made premium

    • Many physicians cannot afford or haven’t planned for this cost

  • How does this cost factor into the “Fair Market Value” of the transaction?

  • Business case for employing physicians vs. cost

  • If you pay for “Prior Acts,” do you also provide “Tail” when physician leaves?

  • 1099 – revenue recognition of the value of prior acts for the physician?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

  • This is third party business:

    • Is it diminimis?

    • Taxes, Excise, UBIT, Self Procurement

    • Conduct of insurance business in violation of state laws?

      • Can I use a trust?

      • Do I need a front?

      • Doing business on shore for an off-shore captive

    • Allocation between “third party” vs. “my party” business

  • Potential difference between tail coverage factors for commercial carriers versus true cost

    • If rigorous reporting to prior carrier, true cost may be closer to 110%-150% of the respective annual mature claims-made premium


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 1

  • Captives probably are most cost effective alternative & have the greatest flexibility

    • Proper review and analysis has yielded success for a number of programs

      • Rigorous reporting to prior carrier

      • Lower overhead

      • Risk margin

      • Investment income

      • You are in control

    • Key is understanding and mitigating risk before assuming it


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 2

The Physician Buys Own “Prior Acts” Coverage From Current Insurer.Sounds Easy And Issues Go Away?

Panel Discussion


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 2

Risk Management Implications:

  • We still need to conduct our due diligence of the physician and practice to include an assessment of exposures, risk management practices, and claims for us to understand the risk we are assuming on a going forward basis

  • We need to underwrite the exposures we are adding to our program

  • We need to orient the physician to our risk management and claims protocol, risk financing programs, allocation of costs, and other requirements


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 2

Claims Management Implications:

  • Transfers tail liability risk to commercial market

    • Physician comes into self-insurance program clean

  • What are the limits purchased and who is the carrier?

    • Does the hospital system weigh in?

    • Are there exposures to the hospital if the physician is under-insured for his tail liability?

    • Financial strength of the commercial insurer/RRG?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 3

Health Care System Funds The

“Prior Acts” For The Physician

Panel Discussion


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 3

Risk Management Implications:

  • We still need to conduct our due diligence in understanding the exposures, and risk management issues and have a good understanding of the claims

  • But under this alternative:

    • Loss of control of “prior acts” claims – no joint defense

    • Need to issue a 1099

    • “Fair market value” of the transaction needs to be considered

  • What are the contractual obligation of either party if the physician leaves?

    • Any pay back provision?

    • Do you provide “tail” coverage for the employment period?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 3

Risk Financing Implications:

  • Pros:

    • Loan serves as “Golden Handcuffs” during term of the loan

    • Simple to administer

  • Cons:

    • Greatest up-front cost for the health care system of any option

    • Can reduce the amount of money available to purchase assets and fund salary (Tail cost part of fair market value)

    • Physician is “free” to leave the health care system at end of 5 years with no tail liability

  • Employment agreement must address:

    • Pre-employment tail liability arrangement

    • Insurance coverage during employment

    • Post employment insurance consequences

    • Fair market value issues

    • Personal income tax issues for the physician


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 3

  • What are the limits purchased and who is the carrier:

    • Does the hospital system weigh in?

  • Financing the tail premium is a major factor in the employment deal

    • Significant expense for the health care system

    • Impact on fair market value for the practice

    • Impact on the physician’s income from the transaction

  • There is a one-time cost for the health care system, but future risk exposure is minimal


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 3

Claims Management Implications:

  • Pros:

    • Transfers tail liability risk to commercial market

    • Physician comes into self-insurance program clean


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 4

  • Health Care System Partners With A Commercial Insurer To Provide “Prior Acts” Coverage For The Physician Upon Employment

    Panel Discussion


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 4

Risk Financing Implications:

  • Commercial Options:

    • Current insurer of the physician

    • Your current insurance partners

    • Other commercial stand-alone programs: Alterra, Lloyd’s, Med Pro, One Beacon, Ironshore, Cooperative of American Physician RRG, and others

    • Portfolio transfers for programs if large physician group is involved

  • Other flexible arrangements and partnerships with a commercial insurer

  • Who is paying the bill?


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 4

  • Pros:

    • No upfront tail cost

    • No tail cost at time of transaction, therefore increases potential portion of “sale price” physician can realize as income

  • Cons:

    • Portion of first 4 years premium for the $1M claims-made policy is imputed income to physician.

    • Complicated to administer

    • Complicated to understand

    • Do we need to establish a reserve on the financials of the captive to account for the “new” employment related tail liability we would be accruing?

    • How does a health care system deal with the tail liability when a physician leaves employment? Remember a portion of it is the health care system’s tail exposure by that time.


Toxic tail strategies for managing old exposures when purchasing new practices

ALTERNATIVE # 4

Claims Management Implications:

  • Control of claims/joint defense

  • Flexibility to change insurers (reinsurers)

  • Denial of coverage?

  • Pros:

    • Commercial carrier responsible for physician’s “prior-acts” coverage and claims-handling

  • Cons:

    • First $1M of coverage is being provided by commercial company for pure premium – health care system gets no benefit from positive claims experience

    • First $1M of each health care system employment related claim not within our control

    • Very complicated to administer (first $1M=commercial coverage; remainder of health care system’s SIR, then excess)

    • Difficult to allocate insurance related responsibility for any large claim (i.e., physician and health care systems named in claim – who pays what could be contested)

    • Do you need approval from excess carriers?


Toxic tail strategies for managing old exposures when purchasing new practices

Conclusion

“Please utilize outside legal and tax counsel, run it by your auditor, and work closely with your broker and actuary.”


  • Login